Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Bepreve, Talion
Bepotastine besilate is a second-generation antihistamine used to treat allergic conjunctivitis. It selectively blocks the histamine H1 receptor, preventing the release of histamine and reducing the allergic response in the eyes. It is available as ophthalmic drops.
For the treatment of itching associated with allergic conjunctivitis.
Outcome:
Enhanced sedation
Mechanism:
Additive CNS depression.
Outcome:
Reduced drug absorption
Mechanism:
Contact lenses can absorb the drug.
Outcome:
Decreased efficacy of either medication
Mechanism:
Dilution or interference with absorption.
Most likely new formulation: sustained-release ophthalmic insert (Year: 2026, 75% confidence)
Based on current usage trends and clinical trial data, there is a 90% likelihood that bepotastine will maintain its current FDA approval status for allergic conjunctivitis.
Antihistamine, H1-receptor antagonist
Benzimidazole derivative